Literature DB >> 26201643

Obesity, type 2 diabetes, age, and female gender: significant risk factors in the development of alcoholic liver cirrhosis.

Yoshinori Horie1,2, Yoshiyuki Yamagishi3, Hirotoshi Ebinuma3, Toshifumi Hibi3.   

Abstract

BACKGROUND: Recent epidemiological studies show that alcoholic liver cirrhosis (ALC) continues to increase in spite of a gradual decrease in the alcohol intake beyond 1999, indicating that there are other risk factors for the development of ALC.
METHODS: A nationwide survey of liver cirrhosis (LC) was undertaken by asking major hospital institutions to provide the number of patients with LC admitted between 2007 and 2008 together with their etiologic findings including the daily intake of alcohol, period of drinking, and other relevant demographic measurements.
RESULTS: The intake of alcohol in female ALC patients was lower together with a shorter drinking period versus male patients. The prevalence of diabetes mellitus (DM) in ALC patients was higher in habitual drinkers (<110 g/day) than in heavy drinkers (≥110 g/day), 49.5 versus 20.3%, respectively (P < 0.001). In male ALC patients, the prevalence of DM was higher in habitual drinkers, 55.2 versus 20.6% for the female gender (P < 0.001). The same tendency was seen in patients with a body mass index ≥25. The prevalence of obesity was higher in habitual drinkers than in heavy drinkers, 49.7 versus 31.1%, respectively. More than 90% of the male habitual drinkers either had DM or were obese, whereas less than half of the female habitual drinkers had a concomitant complication. More than 70% of the male ALC patients were over 60 years.
CONCLUSION: Obesity, DM, age, and female gender appear to be additional significant risk factors for ALC. Our impression is that these additional risk factors might help to identify alcoholic patients who may progress to ALC even without excessive alcohol intake.

Entities:  

Keywords:  Age; Alcoholic liver cirrhosis; Diabetes mellitus; Female gender; Obesity

Year:  2012        PMID: 26201643     DOI: 10.1007/s12072-012-9347-6

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  28 in total

1.  [Status of adolescent drinking habits in Japan: results of the 1996, 2000 and 2004 surveys].

Authors:  Yoneatsu Ozaki; Susumu Higuchi; Kenji Suzuki; Kiyoshi Wada; Takashi Oida; Masumi Minowa; Kensei Tanihata; Kenji Hayash
Journal:  Nihon Arukoru Yakubutsu Igakkai Zasshi       Date:  2007-12

2.  Estrogen is involved in early alcohol-induced liver injury in a rat enteral feeding model.

Authors:  M Yin; K Ikejima; M D Wheeler; B U Bradford; V Seabra; D T Forman; N Sato; R G Thurman
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

3.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

4.  Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics.

Authors:  H Iturriaga; D Bunout; S Hirsch; G Ugarte
Journal:  Am J Clin Nutr       Date:  1988-02       Impact factor: 7.045

5.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

6.  Risk factors of fibrosis in alcohol-induced liver disease.

Authors:  Bruno Raynard; Axel Balian; David Fallik; Frédérique Capron; Pierre Bedossa; Jean-Claude Chaput; Sylvie Naveau
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Gender differences in early alcohol-induced liver injury: role of CD14, NF-kappaB, and TNF-alpha.

Authors:  H Kono; M D Wheeler; I Rusyn; M Lin; V Seabra; C A Rivera; B U Bradford; D T Forman; R G Thurman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-04       Impact factor: 4.052

Review 8.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

9.  Etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:  Kojiro Michitaka; Shuhei Nishiguchi; Yutaka Aoyagi; Yoichi Hiasa; Yoshio Tokumoto; Morikazu Onji
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

10.  Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass.

Authors:  P Y Kwo; V A Ramchandani; S O'Connor; D Amann; L G Carr; K Sandrasegaran; K K Kopecky; T K Li
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

View more
  4 in total

1.  Lifestyle of Patients with Alcoholic Liver Disease and Factors Leading to Hospital Readmission: A Prospective Observational Study.

Authors:  Sung-Mi Park; Nao Saito; Soo Ryang Kim; Ikuko Miyawaki
Journal:  Kobe J Med Sci       Date:  2019-11-12

2.  Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse.

Authors:  Jessica L Mellinger; Kerby Shedden; G Scott Winder; Anne C Fernandez; Brian P Lee; Jennifer Waljee; Robert Fontana; Michael L Volk; Frederic C Blow; Anna S F Lok
Journal:  Liver Int       Date:  2021-02-20       Impact factor: 5.828

3.  Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study.

Authors:  Masahide Hamaguchi; Akihiro Obora; Takuro Okamura; Yoshitaka Hashimoto; Takao Kojima; Michiaki Fukui
Journal:  BMJ Open Gastroenterol       Date:  2020-04-06

4.  Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.

Authors:  Akira Sakamaki; Kunihiko Yokoyama; Kyutaro Koyama; Shinichi Morita; Hiroyuki Abe; Kenya Kamimura; Masaaki Takamura; Shuji Terai
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.